pSivida to raise $21.3m through ADS sale

Perth-headquartered bio-nanotech company pSivida Ltd will raise around $21.3 million through the sale of its American Depository Shares and warrants to pharmaceutical giant Pfizer Inc, under the $203 million research deal announced earlier this year. The company estimates that net proceeds from the offering will be around $19.4 million after deducting placement agent fees and estimated offering expenses.

Add your comment

BNIQ sponsored byECU School of Business and Law


6th-Australian Institute of Management WA20,000
7th-Murdoch University16,584
8th-South Regional TAFE10,549
9th-Central Regional TAFE10,000
10th-The University of Notre Dame Australia6,708
47 tertiary education & training providers ranked by total number of students in WA

Number of Employees

BNiQ Disclaimer